Yu‐Ting Xue

Head-to-head comparisons of [68Ga]Ga-PSMA-11 PET/CT, multiparametric MRI, and prostate-specific antigen for the evaluation of therapeutic responses to neoadjuvant chemohormonal therapy in high-risk non-metastatic prostate cancer patients: a prospective study

Zhi‐Bin Ke, Shaoming Chen, Jia‐Yin Chen et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2022 · 18 citations

Medicine, Nuclear Medicine, Oncology +17

A Liquid–Liquid Phase Separation-Related Index Associate with Biochemical Recurrence and Tumor Immune Environment of Prostate Cancer Patients

Qi You, Jia‐Yin Chen, Xiaohui Wu et al. · International Journal of Molecular Sciences · 2023 · 16 citations · Full text

Medicine, Bioinformatics, Oncology +17

A novel CD8+ T cell-related gene signature for predicting the prognosis and immunotherapy efficacy in bladder cancer

Fei Lin, Zhi‐Bin Ke, Yu‐Ting Xue et al. · Inflammation Research · 2023 · 15 citations

Medicine, Immunology, Oncology +14

Ubiquitin-specific protease 5 promotes bladder cancer progression through stabilizing Twist1

Hai Cai, Zhi‐Bin Ke, Jia‐Yin Chen et al. · Oncogene · 2024 · 14 citations

Medicine, Molecular Biology, Oncology +12

Mechanical signal modulates prostate cancer immune escape by USP8-mediated ubiquitination-dependent degradation of PD-L1 and MHC-1

Zhi‐Bin Ke, Jia‐Yin Chen, Yu‐Ting Xue et al. · Cell Death and Disease · 2025 · 14 citations · Full text

Life Sciences, Biochemistry, Cell Biology +17